Researchers at the University of Texas M.D. Anderson Cancer Center have conducted a new review, indicating that rheumatoid arthritis medications (referred to as biologics) do not raise the risk of cancer, contradicting previous studies. Biologics appear to be particularly effective, as they "work by targeting specific parts of the immune system involved in the inflammation process." Despite this positive outlook, researchers caution that the current study observed drug interaction for a set 24-week period; concerns regarding long-term effectiveness are still unknown at this point.
To read more about this study, click here.
No comments:
Post a Comment